Type 2 Diabetes and Cognitive Impairment: Contributions from Neuroimaging

Overview

Journal J Geriatr Psychiatry Neurol

Publisher Sage Publications

Specialties Geriatrics
Neurology
Psychiatry

Date 2014 Jan 8

PMID 24394151

Citations 42

Authors

John P Ryan

David F Fine

Caterina Rosano

Affiliations

Soon will be listed here.

Abstract

Type 2 diabetes mellitus (T2D) and Alzheimer disease (AD) are major public health burdens associated with aging. As the age of the population rapidly increases, a sheer increase in the incidence of these diseases is expected. Research has identified T2D as a risk factor for cognitive impairment and potentially AD, but the neurobiological pathways that are affected are only beginning to be understood. The rapid advances in neuroimaging in the past decade have added significant understanding to how T2D affects brain structure and function and possibly lead to AD. This article provides a review of studies that have utilized structural and functional neuroimaging to identify neural pathways that link T2D to impaired cognitive performance and potentially AD. A primary focus of this article is the potential for neuroimaging to assist in understanding the mechanistic pathways that may provide translational opportunities for clinical intervention.

Citing Articles

Type II diabetes and cognitive function among older adults in India and China-results from Harmonized Cognitive Assessment Protocol studies.

Srikantha S, Manne-Goehler J, Kobayashi L, Flood D, Koton S, Gross A Front Public Health. 2024; 12:1474593.

PMID: 39568614 PMC: 11576311. DOI: 10.3389/fpubh.2024.1474593.

Okinawa-Based Nordic Diet Decreases Plasma Glial Fibrillary Acidic Protein Levels in Type 2 Diabetes Patients.

Poceviciute D, Wennstrom M, Ohlsson B Nutrients. 2024; 16(17).

PMID: 39275164 PMC: 11396978. DOI: 10.3390/nu16172847.

Special Issue-Diabetes Mellitus: Current Research and Future Perspectives.

Franceschi R J Pers Med. 2024; 14(3).

PMID: 38541050 PMC: 10971381. DOI: 10.3390/jpm14030308.

Affective and Cognitive Impairments in Rodent Models of Diabetes.

Palazzo E, Marabese I, Boccella S, Belardo C, Pierretti G, Maione S Curr Neuropharmacol. 2024; 22(8):1327-1343.

PMID: 38279738 PMC: 11092917. DOI: 10.2174/1570159X22666240124164804.

The hemodynamic response function as a type 2 diabetes biomarker: a data-driven approach.

Guimaraes P, Serranho P, Duarte J, Crisostomo J, Moreno C, Gomes L Front Neuroinform. 2024; 17:1321178.

PMID: 38250018 PMC: 10796780. DOI: 10.3389/fninf.2023.1321178.

References

Craft S, Baker L, Montine T, Minoshima S, Watson G, Claxton A . Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol. 2011; 69(1):29-38. PMC: 3260944. DOI: 10.1001/archneurol.2011.233. View

McNay E, Ong C, McCrimmon R, Cresswell J, Bogan J, Sherwin R . Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance. Neurobiol Learn Mem. 2010; 93(4):546-53. PMC: 2878207. DOI: 10.1016/j.nlm.2010.02.002. View

Kanaya A, Barrett-Connor E, Gildengorin G, Yaffe K . Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med. 2004; 164(12):1327-33. DOI: 10.1001/archinte.164.12.1327. View

Thompson P, Hayashi K, Dutton R, Chiang M, Leow A, Sowell E . Tracking Alzheimer's disease. Ann N Y Acad Sci. 2007; 1097:183-214. PMC: 3197831. DOI: 10.1196/annals.1379.017. View

Yau P, Javier D, Tsui W, Sweat V, Bruehl H, Borod J . Emotional and neutral declarative memory impairments and associated white matter microstructural abnormalities in adults with type 2 diabetes. Psychiatry Res. 2009; 174(3):223-30. PMC: 2788068. DOI: 10.1016/j.pscychresns.2009.04.016. View

Gold M, Alderton C, Zvartau-Hind M, Egginton S, Saunders A, Irizarry M . Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study. Dement Geriatr Cogn Disord. 2010; 30(2):131-46. PMC: 3214882. DOI: 10.1159/000318845. View

Bullmore E, Bassett D . Brain graphs: graphical models of the human brain connectome. Annu Rev Clin Psychol. 2010; 7:113-40. DOI: 10.1146/annurev-clinpsy-040510-143934. View

Nelson P, Smith C, Abner E, Schmitt F, Scheff S, Davis G . Human cerebral neuropathology of Type 2 diabetes mellitus. Biochim Biophys Acta. 2008; 1792(5):454-69. PMC: 2834412. DOI: 10.1016/j.bbadis.2008.08.005. View

van den Berg E, Kloppenborg R, Kessels R, Kappelle L, Biessels G . Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition. Biochim Biophys Acta. 2008; 1792(5):470-81. DOI: 10.1016/j.bbadis.2008.09.004. View

10.

Imfeld P, Bodmer M, Jick S, Meier C . Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study. J Am Geriatr Soc. 2012; 60(5):916-21. DOI: 10.1111/j.1532-5415.2012.03916.x. View

11.

Braak H, Braak E . Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991; 82(4):239-59. DOI: 10.1007/BF00308809. View

12.

Reger M, Watson G, Green P, Wilkinson C, Baker L, Cholerton B . Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology. 2007; 70(6):440-8. DOI: 10.1212/01.WNL.0000265401.62434.36. View

13.

Cole A, Astell A, Green C, Sutherland C . Molecular connexions between dementia and diabetes. Neurosci Biobehav Rev. 2007; 31(7):1046-63. DOI: 10.1016/j.neubiorev.2007.04.004. View

14.

Sabri O, Hellwig D, Schreckenberger M, Schneider R, Kaiser H, Wagenknecht G . Influence of diabetes mellitus on regional cerebral glucose metabolism and regional cerebral blood flow. Nucl Med Commun. 2000; 21(1):19-29. DOI: 10.1097/00006231-200001000-00005. View

15.

Kumar R, Anstey K, Cherbuin N, Wen W, Sachdev P . Association of type 2 diabetes with depression, brain atrophy, and reduced fine motor speed in a 60- to 64-year-old community sample. Am J Geriatr Psychiatry. 2008; 16(12):989-98. DOI: 10.1097/JGP.0b013e31818b40fc. View

16.

Beeri M, Silverman J, Davis K, Marin D, Grossman H, Schmeidler J . Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology. J Gerontol A Biol Sci Med Sci. 2005; 60(4):471-5. PMC: 3163091. DOI: 10.1093/gerona/60.4.471. View

17.

Reitz C, Brayne C, Mayeux R . Epidemiology of Alzheimer disease. Nat Rev Neurol. 2011; 7(3):137-52. PMC: 3339565. DOI: 10.1038/nrneurol.2011.2. View

18.

Strachan M, Reynolds R, Marioni R, Price J . Cognitive function, dementia and type 2 diabetes mellitus in the elderly. Nat Rev Endocrinol. 2011; 7(2):108-14. DOI: 10.1038/nrendo.2010.228. View

19.

Sims-Robinson C, Kim B, Rosko A, Feldman E . How does diabetes accelerate Alzheimer disease pathology?. Nat Rev Neurol. 2010; 6(10):551-9. PMC: 3199576. DOI: 10.1038/nrneurol.2010.130. View

20.

Malek-Ahmadi M, Beach T, Obradov A, Sue L, Belden C, Davis K . Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status. Curr Alzheimer Res. 2013; 10(6):654-9. PMC: 4105218. DOI: 10.2174/15672050113109990006. View